Cardiorenal Syndrome in End-Stage Kidney Disease

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02238093

Enrollment

270

Registered

2014-09-12

Start date

2014-10-31

Completion date

2015-02-28

Last updated

2014-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiorenal Syndrome, End-stage Renal Disease, Heart Disease

Brief summary

Cardiorenal Syndrome (CRS) is prevalent among end-stage renal disease (ESRD) patients. Recently, its prevalence is rising. There are several different clinical presentations of this syndrome. It has a high rate of morbidity and mortality. The purpose of this study is to find the connection between the heart pathology and its effect on ESRD patients. This will aid in choosing the appropriate medical therapy for these patients, and hopefully, aid in increasing their quality of life, and decrease their morbidity and mortality.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* End-stage renal patients

Exclusion criteria

* Cancer patients

Design outcomes

Primary

Measure	Time frame	Description
Heart Pathology Identification	One hour	Visual identification of heart pathology in ESRD patients using echocardiography by measuring the ejection fraction of the left-ventricle during the systolic and diastolic phases. Valvular pathology is measured by the size of the valve.

Countries

Israel

Contacts

Primary ContactNoa Berar-Yanay, MD

noab@hy.health.gov.il972-4-630-4115

Outcome results